您的位置: 首页 > 农业专利 > 详情页

УСТРАНЕНИЕ ЗАВИСИМОСТИ ОТ КОНЦЕНТРАЦИИ КОНТРАСТНОГО АГЕНТА В МРТ
专利权人:
KONINKLEJKE FILIPS EHLEKTRONIKS N.V.
发明人:
LAMERIKHS RUDOLF M. J. N.,ЛАМЕРИХС Рудольф М. Й. Н. (NL),VEG RENE T.,ВЕГ Рене Т. (NL),PIKKEMAT ERUN A.,ПИККЕМАТ Ерун А. (NL),GRUEHLL KHOLGER,ГРУЭЛЛ Хольгер (NL)
申请号:
RU2008152805/15
公开号:
RU0002446829C2
申请日:
2007.06.08
申请国别(地区):
RU
年份:
2012
代理人:
摘要:
FIELD: medicine.SUBSTANCE: invention refers to a method for obtaining the information describing a physical-chemical parameter by the magnetic-resonant tomography (MRT) after a contrast medium is introduced to a patient. Said contrast medium contains a resistant contrast-increasing component giving a first signal with a contrast-increasing ability which is independent of the physical-chemical parameter to be determined, and an unaffected contrast-increasing component giving a second signal different from the first one with the contrast-increasing ability which depends on the physical-chemical parameter to be determined. The declared method involves MRT imaging of a patients body, calibration imaging by recording of the first signal from the resistant contrast-increasing component, and measuring of the physical-chemical parameter by the MRT images and the calibration images with the calibration images being used in order to adjust the physical-chemical parameter to calculate the involvement of the contrast agent concentration in the MRT imaging. Besides, the invention refers to a data medium which stores a machine readable software wherein the method stated above is implemented on a computer. The invention also refers to a MRT system comprising a MRT imaging means, a calibration imaging means, and a means for measuring the physical-chemical parameter, as well as to an intravenous preparation containing the contrast agent specified above.EFFECT: invention provides the decreased or eliminated involvement of the contrast agent involvement in the MRT imaging.29 cl, 3 dwgИзобретение относится к способу получения информации, касающейся физико-химического параметра, посредством магнитно-резонансной томографии (МРТ) после введения пациенту контрастного агента. Указанный контрастный агент содержит невосприимчивый усиливающий контраст-компонент, дающий первый сигнал, со способностью усиливать контраст, которая не зависит от подлежащего определению физико-химического параметра,
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充